We were startled by the shocking news of the severe neurological injuries suffered by French patients participating in trials for a new drug.
Animal testing can only take scientists so far and then human trials are needed to understand just how safe a new chemical compound will be for public use.
No one can deny the benefits pharmaceuticals have brought to the human race and we can only hope the benefit is balanced against the risk of testing.
When you read the warnings on any information sheet provided with a prescription, please remember that someone in a drug trial suffered those symptoms, and those were weighed against the benefits the drug can provide.
A man left brain-dead after an experimental drug trial in France has died, local media report.He was one of six people being treated in hospital in the city of Rennes.The hospital said the other five remained in a stable condition - four had "neurological problems" and the fifth had no symptoms.Reports that the drug was a cannabis-based painkiller have been denied by the French health ministry. The Paris prosecutor has opened an investigationThe trial, which involved taking the drug orally and has now been suspended, was conducted by a private laboratory in Rennes. Ten of the other 84 have been tested, but did not display any of the "anomalies" of those admitted, the Rennes hospital said in its statement (in French).On Friday, the chief neuroscientist at the hospital, Gilles Edan, said there was no known antidote to the drug.